ONgoing Telmisartan Alone or in combination with Ramipril Global Endpoint Trial.
Phase of Trial: Phase IV
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Telmisartan (Primary) ; Ramipril
- Indications Angina pectoris; Cardiovascular disorders; Heart failure; Hypertension; Intermittent claudication; Left ventricular hypertrophy; Myocardial infarction; Stroke; Unstable angina pectoris
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Acronyms ONTARGET
- Sponsors Boehringer Ingelheim
- 01 Feb 2013 Results published in the Journal of Hypertension.
- 31 Aug 2011 Patient adherence results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 30 Aug 2010 A late-breaking analysis reviewing 21 trials, including ONTARGET, was presented at the European Society of Cardiology (ESC) Congress, according to a European Society of Cardiology media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History